Related Experiment Video
Updated: Feb 11, 2026

09:41
Formulating and Characterizing Lipid Nanoparticles for Gene Delivery using a Microfluidic Mixing Platform
Published on: February 25, 2021
25.4K
Otic drug delivery systems: formulation principles and recent developments
Xu Liu1, Mingshuang Li2, Hugh Smyth1
1a College of Pharmacy , The University of Texas at Austin , Austin , TX , USA.
Drug Development and Industrial Pharmacy
|April 17, 2018
Summary
Ear disorder treatments face formulation challenges. Innovations in otic drug delivery systems are crucial for improving the efficacy of ear disease therapies.
Area of Science:
- Otolaryngology
- Pharmaceutics
- Drug Delivery Systems
Background:
- Ear disorders significantly impact millions globally, necessitating improved therapeutic strategies.
- Current treatments for ear diseases often lack innovation in drug formulation and delivery systems.
- The otic route of administration presents unique challenges for drug product development.
Purpose of the Study:
- To review the physiology and major diseases of the ear.
- To examine current therapies and formulation principles for otic drug administration.
- To highlight recent advances and limitations in otic drug delivery technology.
Main Methods:
- Literature review of ear physiology, diseases, and otic administration routes.
- Analysis of formulation principles for various otic delivery methods.
- Synthesis of recent advancements and future trends in otic drug delivery.
Main Results:
- The otic route requires specialized formulation design for effective drug delivery.
- Significant progress has been made in developing novel otic drug delivery systems.
- Limitations exist in current systems, including invasiveness and control.
Conclusions:
- Advancements in otic drug delivery are essential for enhancing ear disease treatment efficacy.
- Future developments will focus on less invasive, controlled, and targeted therapies.
- Biotechnology holds promise for more specific and effective treatments for ear disorders.
Related Concept Videos
Insulin Formulations: Types and Delivery
794
Insulin preparations are categorized by their duration of action into short-acting and long-acting types. Two strategies are used to modify insulin's absorption and pharmacokinetic profile: slowing the absorption post-subcutaneous injection, or altering human insulin's amino acid sequence or protein structure. These changes retain the insulin's ability to bind to the insulin receptor, but alter its behavior in solution or after injection.
Short-acting insulins are divided into...
Short-acting insulins are divided into...
794
Principles of Drug Action
8.8K
Drugs are chemical substances that modify biological responses by interacting with macromolecular targets such as receptors, ion channels, transporters, and enzymes. Pharmacodynamics describes the course of action of drugs leading to the physiological effect at a specific site in the body.
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
Drugs can be agonists or antagonists. Like the endogenous ligands, agonists always bind and activate the target to produce a cellular response. Agonist binding induces a conformational change which in turn...
8.8K
Drug Delivery: Overview
914
The selection of a drug's delivery route depends upon its physicochemical properties, including lipid or water solubility and ionization, as well as the therapeutic requirement, such as immediate or sustained effect. These routes can be divided into three primary categories: enteral, parenteral, and topical.
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
Enteral delivery involves administering drugs directly through swallowing, sublingual placement, or buccal application. Orally administered drugs predominantly navigate the...
914
Drug Delivery: Enteral Route
1.9K
The enteral drug administration involves three primary routes: oral, sublingual, and buccal. Oral ingestion is the most prevalent, safe, economical, and convenient method for drug administration. However, it has certain drawbacks, including limited absorption due to the drug's low water solubility or poor membrane permeability, possible emesis from GI mucosa irritation, destruction of drugs by digestive enzymes or low gastric pH, and irregular absorption along with food or other drugs.
1.9K
Drug Delivery: Parenteral Route
1.8K
The parenteral route is a critical method of drug administration. It delivers compounds directly into the systemic circulation and bypasses the gastrointestinal tract. This approach is particularly advantageous for drugs that exhibit poor absorption or instability when administered orally.
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
There are three primary parenteral routes: intravenous (IV), intramuscular (IM), and subcutaneous (SC). The IV route introduces the drug directly into the bloodstream, ensuring immediate action. The IM route...
1.8K
Drug Delivery: Miscellaneous Routes
837
Drug delivery methods like oral inhalation, nasal sprays, transdermal patches, eye drops, intravitreal injection, and rectal administration provide localized effects with reduced toxicity.
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
Oral inhalation and nasal sprays swiftly transfer drugs across the respiratory epithelium's mucosal layer. Inhaled glucocorticoids and bronchodilators directly target lung conditions such as asthma, while fluticasone nasal spray mitigates allergic rhinitis.
Transdermal patches transport drugs...
837

